Jessica Hagen
The company is adding three nutrition tools to its platform that allow providers to supply food recommendations, recipes and tailored grocery lists to their patients.
The company's product, Prism, uses neurofeedback to help PTSD patients learn to control their emotional response.
The AI-powered app allows for remote monitoring of common Parkinson's disease symptoms such as bradykinesia, tremor and dyskinesia via an Apple Watch.
The company will use the funds to advance the study of its neuromodulation device intended to treat Alzheimer's disease.
A study published in The New England Journal of Medicine found a closed-loop control system kept children's glucose levels in the target range longer than standard care.
Blood-collection device-maker Vitestro, tech-enabled baby bottle designer Emulait, digital health support platform Reveal HealthTech and AI-based testing platform PocDoc also received funding.
The company will use the funds to circulate its ArteraAI Prostate Test and to develop tests to support individualized therapy options for other cancers.
The collaboration will expand MedArrive's maternal care services for managed Medicaid health plan members.
Ida Tin, cofounder and chairwoman at Clue, explains how she sees the fall of Silicon Valley Bank affecting femtech investments and how the sector could progress fruitfully.
The company also announced a new payer network and revenue cycle management service.